MedPath

A prospective observational study to evaluate the impact of neuropathic pain components on pain response to radiotherapy for painful tumors

Not Applicable
Recruiting
Conditions
Painful tumors
Registration Number
JPRN-UMIN000029579
Lead Sponsor
Kumamoto University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
250
Inclusion Criteria

Not provided

Exclusion Criteria

1. Some other tumor has more severe pain than the tumor planned to receive radiotherapy 2. Painful tumor planned to receive radiotherapy was previously irradiated

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain response within three months after the start of radiotherapy
Secondary Outcome Measures
NameTimeMethod
Pain intensity, Analgesic use, Functional interference, Performance status, Adverse events, Other painful lesions
© Copyright 2025. All Rights Reserved by MedPath